Systems Pharmacology and Toxicology Training Program
Systems Pharmacology and Toxicology Training Program
批准号:
10394415
负责人:
Paul L Prather
金额:
$16.82万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2023-06-30
中文摘要
项目摘要/摘要:
在过去的几十年里,我们对细胞与药物和毒素相互作用机制的了解
由于新的分子分析技术和基因组方法的应用而爆炸。因此,
药理学和毒理学学科研究生教育的重点需要从
一种系统的观点,博士生受到全面的培训,这样他们就可以
制定一项战略,不仅在分子、细胞和组织层面解决重要的生物学问题
而且在整个动物层面上也是如此。系统药理学和毒理学描述了一个研究领域,它考虑到
对毒品行为的广泛看法。使用活体动物模型的系统方法对于确定疗效是必要的,
候选药物的安全性和药效学/药动学概况但学生短缺
在这方面受过训练。本系统药理学和毒理学(SPAT)课程是为博士生设计的
在他们攻读药理学学位论文研究项目的第二年。
实习生(两年/年,最多两年的支持)和培训教师(30名导师和4名教师)从
跨学科生物医学研究生课程和医学博士课程。口水战计划
将培训学生使用活体方法回答药理学和毒理学的相关问题
重点是新陈代谢、药物设计、药效学、药代动力学和信号传递。其基本原理是
对于Spat来说,这种类型的培训为学生提供了更广阔的药理学和
毒理学,使他们更好地准备成为药理学领域多学科研究团队的领导者
科学。我们将把SPAT整合到已经在我们的研究生培训地点活跃的博士培训计划中
小石区,包括医学院、药房和公共卫生学院的教职员工/科学家
UAMS,阿肯色州儿童医院校园,以及食品和药物管理局资助的国家
毒理研究中心。SPAT的独特焦点是用体内药理系统进行训练
以及毒理学方法和概念。SPAT的目标是提供体内药理学和
毒理学培训,补充学生在家中接受的细胞和分子培训
程序。培训计划包括药理学、毒理学、生理学、
药代动力学、新陈代谢、生物统计学、拨款撰写和负责任的研究
使用活体人类疾病模型的实验室研究。SPAT计划还将提供强有力的
通过ITS为学员提供指导、广泛的网络以及教学和领导机会
程序性活动。
英文摘要
Project Summary/Abstract:
Over the past few decades, our knowledge of the mechanisms by which cells interact with drugs and toxins has
exploded due to new molecular analysis techniques and the application of genomic methods. Accordingly, the
emphasis of graduate education in the disciplines of pharmacology and toxicology needs to shift from a
reductionist view to a systems approach in which doctoral students are comprehensively trained so they can
formulate a strategy to solve important biological questions not only at the molecular, cellular, and tissue levels
but also at the whole-animal level. Systems pharmacology and toxicology describes a field of study that considers
the broad view of drug action. A systems approach using in vivo animal models is necessary to establish efficacy,
safety and the pharmacodynamic/pharmacokinetic profile of candidate drugs but there is a shortage of students
trained in this area. This Systems Pharmacology and Toxicology (SPaT) Program is designed for PhD students
in their second year of graduate study pursuing dissertation research projects in the pharmacological sciences.
Trainees (2/year for up to 2 years of support) and training faculty (30 mentors and 4 teachers) are drawn from
the Graduate Program in Interdisciplinary Biomedical Sciences and the MD/PhD Program. The SPaT program
will train students to use an in vivo approach to answering relevant questions in pharmacology and toxicology
with emphasis on metabolism, drug design, pharmacodynamics, pharmacokinetics, and signaling. The rationale
for SPaT is that this type of training provides students with a much broader perspective on pharmacology and
toxicology that better prepares them to be leaders of multi-disciplinary research teams in the pharmacological
sciences. We will integrate SPaT into PhD training programs already active at our graduate training sites in the
Little Rock area that include faculty/scientists in the Colleges of Medicine, Pharmacy, and Public Health on the
UAMS, the Arkansas Children's Hospital campus, and at the Food and Drug Administration-funded National
Center for Toxicological Research. The unique focus of SPaT is training with in vivo systems pharmacological
and toxicological approaches and concepts. The objective of SPaT is to provide in vivo pharmacology and
toxicology training that complement the cellular and molecular training that students receive in their home
programs. The training program consists of didactic training in pharmacology, toxicology, physiology,
pharmacokinetics, metabolism, biostatistics, grant writing, and the Responsible Conduct of Research along with
laboratory research using an in vivo model of human disease. The SPaT program will also provide strong
mentoring, extensive networking, and teaching and leadership opportunities for its trainees through its
programmatic activities.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0185542
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Parajuli N, Shrum S, Tobacyk J, Harb A, Arthur JM, MacMillan-Crow LA]
通讯作者:
MacMillan-Crow LA
Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.
耳蜗中药物代谢酶和转运蛋白的表达:对药物输送和耳毒性的影响。
DOI:
10.1016/j.heares.2019.05.002
发表时间:
2019
期刊:
Hearing research
影响因子:
2.8
作者:
[Kennon-McGill,Stefanie, Clemens,MelissaM, McGill,MitchellR]
通讯作者:
McGill,MitchellR
DOI:
10.3390/livers1040022
发表时间:
2021-12
期刊:
Livers
影响因子:
--
作者:
[Vazquez JH, McGill MR]
通讯作者:
McGill MR
DOI:
10.3389/fcvm.2023.1129384
发表时间:
2023
期刊:
FRONTIERS IN CARDIOVASCULAR MEDICINE
影响因子:
3.6
作者:
[Benson, Lance N., Guo, Yunping, Deck, Katherine, Mora, Christoph, Liu, Yunmeng, Mu, Shengyu]
通讯作者:
Mu, Shengyu
DOI:
10.3390/antiox10081272
发表时间:
2021-08-11
期刊:
Antioxidants (Basel, Switzerland)
影响因子:
--
作者:
[Tobacyk J, Kc G, MacMillan-Crow LA]
通讯作者:
MacMillan-Crow LA
Training in Systems Pharmacology and Toxicology (T-SPaT)
-
批准号:10714918
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2023
-
负责人:Paul L Prather
-
依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
-
批准号:9520656
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2016
-
负责人:Paul L Prather
-
依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
-
批准号:9914444
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2016
-
负责人:Paul L Prather
-
依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
-
批准号:9037178
-
项目类别:
-
资助金额:$54.97万
-
财政年份:2016
-
负责人:Paul L Prather
-
依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
-
批准号:9272377
-
项目类别:
-
资助金额:$53.97万
-
财政年份:2016
-
负责人:Paul L Prather
-
依托单位:
Systems Pharmacology and Toxicology Training Program
-
批准号:10166861
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2013
-
负责人:Paul L Prather
-
依托单位:
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS
-
批准号:7884988
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2008
-
负责人:Paul L Prather
-
依托单位:
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS
-
批准号:7533341
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2008
-
负责人:Paul L Prather
-
依托单位:
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS
-
批准号:7884989
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2008
-
负责人:Paul L Prather
-
依托单位:
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION
-
批准号:6497837
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2001
-
负责人:Paul L Prather
-
依托单位:
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION
-
批准号:6706924
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2001
-
负责人:Paul L Prather
-
依托单位:
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION
-
批准号:6232993
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2001
-
负责人:Paul L Prather
-
依托单位:
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION
-
批准号:6628361
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2001
-
负责人:Paul L Prather
-
依托单位:
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION
-
批准号:6342268
-
项目类别:
-
资助金额:$9.65万
-
财政年份:1998
-
负责人:Paul L Prather
-
依托单位:
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION
-
批准号:2502171
-
项目类别:
-
资助金额:$10.85万
-
财政年份:1998
-
负责人:Paul L Prather
-
依托单位:
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION
-
批准号:6137807
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1998
-
负责人:Paul L Prather
-
依托单位:
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION
-
批准号:6489483
-
项目类别:
-
资助金额:$9.81万
-
财政年份:1998
-
负责人:Paul L Prather
-
依托单位:
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION
-
批准号:2856561
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1998
-
负责人:Paul L Prather
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于铁死亡探讨黄芪甲苷调控System/Xc-/GSH/GPX4信号通路在神经损伤性勃起功能障碍治疗中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:马轲
-
依托单位:
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
-
批准号:--
-
项目类别:外国青年学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:江洋子
-
依托单位:
TBX1/LKB1轴阻断system Xc活性调控AML细胞铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:
-
依托单位:
TET2通过调控BAP1-System Xc-轴促进紫拉非尼诱导的肝细胞癌铁死亡的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:--
-
依托单位:
P3H1通过ATF4/System Xc-轴抑制肾癌铁死亡和抗肿瘤免疫反应的作用及机制研究
-
批准号:82372704
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王保军
-
依托单位:
基于PNO1介导system Xc-/GSH途径调控肠上皮细胞自噬依赖性铁死亡探讨加味胶七散治疗溃疡性结肠炎的机制
-
批准号:82304982
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘伟萍
-
依托单位:
基于单细胞测序探讨淫羊藿苷对Erastin诱导髓核细胞铁死亡相关system-Xc/GSH/GPX4分子轴线的调控作用
-
批准号:82360947
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2023
-
负责人:张彦军
-
依托单位:
内皮细胞机械敏感离子通道Piezo1通过HIF-1α/system Xc-介导BBB破坏在急性脑缺血再灌注损伤中的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王德任
-
依托单位:
miR-198 靶向 Nrf2 抑制 System Xc-通路调控滋养细胞铁死亡在子痫前期中的机制
-
批准号:2022JJ70123
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:阳双健
-
依托单位:
BAP1介导H2B去泛素化抑制System Xc-在蛛网膜下腔出血神经元铁死亡中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:李明昌
-
依托单位: